The global ortho phthalaldehyde market is experiencing consistent expansion due to the growing need for advanced sterilization and disinfection solutions across healthcare and laboratory settings. The market size was valued at USD 6.28 billion in 2024 and is projected to grow from USD 6.61 billion in 2025 to USD 9.93 billion by 2033, registering a CAGR of 5.23% during the forecast period.
Ortho phthalaldehyde (OPA) is widely recognized as an effective high-level disinfectant and chemical reagent extensively used in healthcare facilities, pharmaceutical manufacturing, analytical chemistry, and biochemical applications. Its superior antimicrobial activity, low odor, broad material compatibility, and FDA-approved sterilization properties continue to drive market demand globally.
Rising Hospital-Acquired Infections Fuel Market Expansion
The increasing prevalence of hospital-acquired infections (HAIs) is a major factor accelerating the adoption of ortho phthalaldehyde-based disinfection solutions. Healthcare facilities worldwide are emphasizing stringent infection prevention and sterilization protocols to minimize the spread of dangerous pathogens.
According to the Centers for Disease Control and Prevention (CDC), hospital-acquired infections account for approximately 687,000 illnesses and nearly 72,000 deaths annually in the United States. OPA-based disinfectants are increasingly utilized to sterilize heat-sensitive medical instruments and healthcare equipment due to their strong antimicrobial effectiveness against bacteria, spores, and mycobacteria.
Growing awareness regarding infection control in hospitals, clinics, diagnostic laboratories, and surgical centers is expected to continue supporting market growth throughout the forecast period.
Technological Advancements Driving Product Innovation
Rapid advancements in chemical manufacturing and sterilization technologies are creating new opportunities in the ortho phthalaldehyde market. Research collaborations between healthcare institutions, chemical manufacturers, and safety organizations are enabling the development of safer, more efficient, and environmentally compatible disinfectant formulations.
OPA has emerged as a preferred alternative to glutaraldehyde because of its lower irritation potential, improved safety profile, and high-level disinfection performance. The chemical is also increasingly used in amino acid analysis, histamine evaluation, protein modification, and high-performance liquid chromatography (HPLC) applications.
The growing adoption of sophisticated analytical techniques and biomedical research activities is further expanding the commercial scope of ortho phthalaldehyde worldwide.
Regulatory Challenges and Raw Material Costs Remain Key Concerns
Despite positive growth prospects, the market faces challenges associated with high raw material costs and stringent regulatory requirements. The handling of ortho phthalaldehyde requires strict occupational safety measures due to potential aerosol toxicity concerns.
Regulatory authorities including the U.S. Food and Drug Administration (FDA) and the National Institute for Occupational Safety and Health (NIOSH) continue to monitor the safe use and reprocessing standards of OPA-based disinfectants in healthcare environments. Compliance with evolving safety guidelines and manufacturing standards may increase operational complexities for manufacturers.
North America Dominates Global Market Revenue
North America remains the largest shareholder in the global ortho phthalaldehyde market and is projected to maintain steady growth during the forecast period. The region’s dominance is supported by advanced healthcare infrastructure, increasing preference for OPA over glutaraldehyde, and rising demand for reusable disinfection solutions.
The growing number of hospitals, surgical procedures, and infection control initiatives across the United States and Canada continues to strengthen regional demand for high-level disinfectants and sterilization chemicals.
Asia Pacific Emerging as Fastest-Growing Regional Market
Asia Pacific is expected to witness substantial growth owing to expanding healthcare infrastructure, rising public awareness regarding infection prevention, and increasing investments in medical facilities across countries such as China, India, Japan, and South Korea.
The growing volume of surgeries and medical procedures, coupled with the rising prevalence of healthcare-associated infections, is accelerating demand for advanced sterilization products throughout the region. Additionally, increased adoption of OPA-based disinfectants in laboratories and pharmaceutical applications is contributing to strong regional market growth.
Disinfection Segment Holds Largest Market Share
Based on end-user segmentation, the Disinfection segment accounted for the largest market share and is projected to continue its dominance during the forecast period. OPA is widely used as a high-level disinfectant for medical instruments because of its rapid action time and broad-spectrum antimicrobial activity.
The Amino Acids and Detection segment dominated the application category due to the growing use of OPA in amino acid derivatization and fluorescence detection processes used in analytical chemistry and HPLC systems.
Competitive Landscape Strengthens Through Innovation and Expansion
Leading companies operating in the global ortho phthalaldehyde market are focusing on product innovation, strategic collaborations, and expansion of specialty chemical portfolios to strengthen their market presence.
Key market participants include:
- MP Biomedicals LLC
- Sigma-Aldrich Co. LLC
- TCI America
- Parchem Fine & Specialty Chemicals
- DPX Fine Chemicals
- Thermo Fisher Scientific Inc.
- Merck Millipore Corporation
- Alfa Aesar
- AK Scientific Inc
In January 2023, Thermo Fisher Scientific Inc. acquired The Binding Site Group in an all-cash transaction valued at approximately EUR 2.3 billion, strengthening its specialty diagnostics capabilities. Additionally, MP Biomedicals LLC launched the third generation Automated Nucleic Acid Purification system, MPure-32, in March 2022.
Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Market Report Overview here:
About Us:
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.
Contact Us:
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
